Grant: Discovery Grants Program - Individual
Carleton University
$33,000.00
Stimulating neuronal intrinsic mechanisms to promote nerve regeneration in the CNS
FY 2020-21
Summary
Adult central nervous system (CNS: brain, spinal cord and visual system) neurons do not spontaneously regenerate their axons (nerves) following an injury. It has been previously suggested that these neurons do not possess the capacity for re-growth after injury, but we are now beginning to appreciate that this is not the case. The pioneering work of researchers, such as Aguayo and colleagues, has challenged the idea that CNS neurons cannot regenerate axons. Indeed, it is now well established that the combined effect of the inhibitory CNS environment after injury, coupled with a developmental loss of nerve growth, plays a key role in limiting axon regeneration. The growth inhibitory characteristics of the CNS environment has been studied extensively, but the potential impact of manipulating the CNS environment on regeneration remains controversial. Research has now converged on the emerging hypotheses that enhancing the intrinsic capability of adult CNS neurons may be an effective strategy to promote regeneration in the CNS. My previous work has contributed to this knowledge, by demonstrating that manipulating specific molecules in the CNS could be effective at enhancing axon regeneration in animal models. Of particular relevance, we have identified two key regulators of nerve regeneration, one called PTEN (phosphatase and tensin homolog on Chromosome 10) and the other known as SOCS3 (suppressor of cytokine signalling 3). The mechanisms mediating this regenerative response are still not clear. My research program is geared toward understanding the mechanisms that promote axon growth during development, as well as the molecular signals that are activated in response to nerve injury to gain better insight into ways of enhancing nerve regeneration in the CNS. We have recently found that a pharmaceutical agent, known as GM-CSF (granulocyte macrophage colony stimulating factor) is effective at promoting regeneration of isolated CNS neurons (in vitro; petri-dish experiments). We still do not know the mechanisms that are used by the compound to drive regeneration and it is not clear whether treatment with this agent will promote regeneration in a physiological setting (in vivo). We propose to use several advanced neuroscience techniques (in vitro and in vivo animal models which we have already established) to evaluate the mechanisms required to promote regeneration in the adult CNS. We hypothesize that activating specific molecular mechanisms in CNS neurons will be effective at enhancing nerve regeneration of both developing and adult CNS neurons. A particular target of our investigations is a molecule known as JAK2 (Janus kinase 2), which can be activated by GM-CSF. We propose to use pharmacological and genetic approaches to express JAK2 in CNS neurons and evaluate the impact on axon growth in vitro and in vivo, thus defining a possible mechanism involved in developmental loss of CNS axon growth ability.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2016-06259
Name nom
Smith, Patrice
Department département
Neuroscience
Organization id
23
Institution établissement
Carleton University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2016
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Installment
inst:5-6
Partie
2
Nb partie
6
Application title
Stimulating neuronal intrinsic mechanisms to promote nerve regeneration in the CNS
Keyword
NSERC
Application summary
Adult central nervous system (CNS: brain, spinal cord and visual system) neurons do not spontaneously regenerate their axons (nerves) following an injury. It has been previously suggested that these neurons do not possess the capacity for re-growth after injury, but we are now beginning to appreciate that this is not the case. The pioneering work of researchers, such as Aguayo and colleagues, has challenged the idea that CNS neurons cannot regenerate axons. Indeed, it is now well established that the combined effect of the inhibitory CNS environment after injury, coupled with a developmental loss of nerve growth, plays a key role in limiting axon regeneration. The growth inhibitory characteristics of the CNS environment has been studied extensively, but the potential impact of manipulating the CNS environment on regeneration remains controversial. Research has now converged on the emerging hypotheses that enhancing the intrinsic capability of adult CNS neurons may be an effective strategy to promote regeneration in the CNS. My previous work has contributed to this knowledge, by demonstrating that manipulating specific molecules in the CNS could be effective at enhancing axon regeneration in animal models. Of particular relevance, we have identified two key regulators of nerve regeneration, one called PTEN (phosphatase and tensin homolog on Chromosome 10) and the other known as SOCS3 (suppressor of cytokine signalling 3). The mechanisms mediating this regenerative response are still not clear. My research program is geared toward understanding the mechanisms that promote axon growth during development, as well as the molecular signals that are activated in response to nerve injury to gain better insight into ways of enhancing nerve regeneration in the CNS. We have recently found that a pharmaceutical agent, known as GM-CSF (granulocyte macrophage colony stimulating factor) is effective at promoting regeneration of isolated CNS neurons (in vitro; petri-dish experiments). We still do not know the mechanisms that are used by the compound to drive regeneration and it is not clear whether treatment with this agent will promote regeneration in a physiological setting (in vivo). We propose to use several advanced neuroscience techniques (in vitro and in vivo animal models which we have already established) to evaluate the mechanisms required to promote regeneration in the adult CNS. We hypothesize that activating specific molecular mechanisms in CNS neurons will be effective at enhancing nerve regeneration of both developing and adult CNS neurons. A particular target of our investigations is a molecule known as JAK2 (Janus kinase 2), which can be activated by GM-CSF. We propose to use pharmacological and genetic approaches to express JAK2 in CNS neurons and evaluate the impact on axon growth in vitro and in vivo, thus defining a possible mechanism involved in developmental loss of CNS axon growth ability.